Benzinga’s Top Pre-Market NASDAQ Losers (MNKD, MAIN, NVAX, QGEN)
Posted in: Earnings, News, Downgrades, Offerings, Pre-Market Outlook, Intraday Update, Markets, Analyst Ratings, Trading Ideas
MannKind Corporation (NASDAQ: MNKD) dipped 7.04% to $6.34 in the pre-market session. MNKD has announced the proposed offering of about 8,000,000 shares of its common stock.
Main Street Capital Corporation (NASDAQ: MAIN) lost 3.71% to $15.04 in the pre-market session. Analysts at Ladenburg Thalmann downgraded MAIN from “buy” to “neutral.”
Novavax Inc (NASDAQ: NVAX) fell 0.93% to $2.14 in the pre-market session. NVAX had reported positive results from its pre-clinical toxicology study of its vaccine candidate for preventing respiratory syncytial virus (RSV).
Qiagen NV (NASDAQ: QGEN) slipped 0.28% to $18 in pre-market trading. QGEN had reported strong Q2 results.
Read more from Benzinga's Company news.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
